Larvol Delta - Imara-Announces-Completion-of-Patient-Enrollment-in-Ardent-Phase-2b-Clinical-Trial-of-IMR687-tovinontrine-for-Sickle-Cell-Disease

tovinontrine (IMR-687) - Imara, Inc

https://www.globenewswire.com/news-release/2021/08/05/2275454/0/en/Imara-Announces-Completion-of-Patient-Enrollment-in-Ardent-Phase-2b-Clinical-Trial-of-IMR-687-tovinontrine-for-Sickle-Cell-Disease.html

Aug 5, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next